ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,084 DKK | -1.45% |
|
-0.97% | -18.51% |
| 03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 1,224.40 | 1,400.00 | 2,905.00 |
| Spread/Res. | -11.48% | -22.59% | -62.69% |
| Spread/Supp. | +7.84% | +60.14% | +54.83% |
| Support | 1,005.00 | 676.80 | 700.00 |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
